Follow The Filings

IRLA IRulya Therapeutics

IRulya Therapeutics earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by IRLA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All IRLA insider trades
  • None no insider bought on the open market
  • $174K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Luca Benatti Director
    Sale
    $174K 50,000 shares at $3.47 56% of stake
    Traded Dec 26, 2025 Filed Dec 29, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 2 gifts and 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02,5.03,7.01,8.01,9.01 Filing Doc
8-K 5.02,5.03,5.07,9.01 Filing Doc
DEFA14A Filing Doc
8-K 5.02 Filing Doc
8-K 2.01,5.02,9.01 Filing Doc
8-K 3.01 Filing Doc
8-K 5.02 Filing Doc
DEF 14A Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02 Filing Doc
8-K/A 8.01,9.01 Filing Doc
8-K 3.03,5.03,9.01 Filing Doc
8-K/A 3.03 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.